Vantaa, Finland

Päivi Lindholm

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Herantis Pharma Plc., Herantis Pharma Oyj, Licentia, Ltd.. Active years: 2008-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Päivi Lindholm. Retrieved from https://idiyas.com/inventor/paivi-lindholm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Päivi Lindholm: Innovator in Neurotrophic Factor Research

Introduction

Päivi Lindholm is a notable inventor based in Vantaa, Finland. He has made significant contributions to the field of neurotrophic factors and their applications in treating various neuronal disorders. With a total of 4 patents, his work focuses on innovative methods for addressing conditions such as Alzheimer's disease and Parkinson's disease.

Latest Patents

Lindholm's latest patents include groundbreaking methods for treating conditions through pharmaceutical compositions. One of his notable inventions is a method for treating conditions selected from Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke, and peripheral neuropathy. This method involves administering a pharmaceutically effective amount of a composition comprising the MANF2 polypeptide or a functional fragment thereof. Another significant patent relates to the neurotrophic factor MANF, which provides a pharmaceutical compound for treating peripheral neuropathy, including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury.

Career Highlights

Throughout his career, Lindholm has worked with various companies, including Licentia Ltd. and Herantis Pharma Oyj. His expertise in neurotrophic factors has positioned him as a key figure in the development of treatments for neuronal disorders. His innovative approaches have garnered attention in the scientific community.

Collaborations

Lindholm has collaborated with esteemed colleagues such as Mart Saarma and Raimo Tuominen. These partnerships have further advanced his research and contributed to the development of effective treatments in the field.

Conclusion

Päivi Lindholm's contributions to neurotrophic factor research and his innovative patents highlight his role as a leading inventor in the treatment of neuronal disorders. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…